In a major breakthrough for finding a cure, researchers have identified a genetic cause for epilepsy, which could lead to the development of medicines to treat epilepsy and autism, the Translational Genomics Research Institute announced Thursday.

Dr. Dietrich Stephan, director of the neurogenomic division of TGen told The Associated Press, "this is the first step" in finding a cure for the childhood-onset diseases

Researchers have found the first link between human lissencephaly and the mouse form of the disease, leading them a closer to understanding the basis of severe epilepsy and mental retardation syndrome.

Joseph Gleeson, M.D., Director of the Neurogenetics Laboratory at the UCSD School of Medicine, and his team developed a mouse model for the severe brain disorder in newborn children, also known as "smooth brain," reports Newswise

Researchers have found the first link between human lissencephaly and the mouse form of the disease, leading them a closer to understanding the basis of severe epilepsy and mental retardation syndrome.

Joseph Gleeson, M.D., Director of the Neurogenetics Laboratory at the UCSD School of Medicine, and his team developed a mouse model for the severe brain disorder in newborn children, also known as "smooth brain," reports Newswise

Leading pharmaceutical company, AstraZeneca, in letters released by the Food and Drug Administration, warn doctors and pharmacists that mix-ups in prescriptions of three drugs with similar names, but vastly different effects can lead to serious health problems.

The drugs are Toprol-XL, Topamax, and Tegretol

Although many doctors remain skeptical, there is some rays of hope in the fight of the HIV virus according to details released in the August 13 edition of The Lancet.

Researchers have discovered that the drug valproic acid (Depakote) may be able to reduce the pool of dormant HIV-infected cells in the body